Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Portola Pharmaceuticals Inc (PTLA) A Good Stock To Buy?

Page 1 of 2

The market has been volatile as the Federal Reserve winds down its easy money policies. Small cap stocks have been hit hard as a result, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 14 percentage points between June 25th and the end of October. SEC filings and hedge fund investor letters indicate that the smart money seems to be paring back their overall long exposure, and the funds’ movements is one of the reasons why the major indexes have retraced. In this article, we analyze what the smart money thinks of Portola Pharmaceuticals Inc (NASDAQ:PTLA) and find out how it is affected by hedge funds’ moves.

Portola Pharmaceuticals Inc (NASDAQ:PTLA) investors should pay attention to an increase in hedge fund sentiment in recent months. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as CONSOL Energy Inc. (NYSE:CNX), Cooper Tire & Rubber Company (NYSE:CTB), and Primerica, Inc. (NYSE:PRI) to gather more data points.

Follow Portola Pharmaceuticals Inc (NASDAQ:PTLA)
Trade (NASDAQ:PTLA) Now!

At the moment there are many indicators stock market investors can use to appraise publicly traded companies. A duo of the less utilized indicators are hedge fund and insider trading sentiment. We have shown that, historically, those who follow the best picks of the best hedge fund managers can beat the market by a solid margin (see the details here).

Keeping this in mind, we’re going to review the recent action surrounding Portola Pharmaceuticals Inc (NASDAQ:PTLA).

How have hedgies been trading Portola Pharmaceuticals Inc (NASDAQ:PTLA)?

Heading into Q4, a total of 26 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 8% from the previous quarter. With the smart money’s sentiment swirling, there exists an “upper tier” of key hedge fund managers who were increasing their stakes considerably (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Jeremy Green’s Redmile Group has the most valuable position in Portola Pharmaceuticals Inc (NASDAQ:PTLA), worth close to $392 million, accounting for 9% of its total 13F portfolio. Coming in second is Ken Griffin’s Citadel Investment Group, with a $51 million position; less than 0.1%% of its 13F portfolio is allocated to the stock. The remaining members of the smart money with similar optimism contain Jerome Pfund and Michael Sjostrom’s Sectoral Asset Management, Israel Englander’s Millennium Management, and Samuel Isaly’s OrbiMed Advisors.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!